🇺🇸 biological therapy in United States
9 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 9
Most-reported reactions
- Carotid Arteriosclerosis — 1 report (11.11%)
- Cerebral Atrophy — 1 report (11.11%)
- Hemiparesis — 1 report (11.11%)
- Ischaemic Cerebral Infarction — 1 report (11.11%)
- Lacunar Infarction — 1 report (11.11%)
- Loss Of Consciousness — 1 report (11.11%)
- Lung Infection — 1 report (11.11%)
- Platelet Count Decreased — 1 report (11.11%)
- Subdural Haemorrhage — 1 report (11.11%)
Other Oncology approved in United States
Frequently asked questions
Is biological therapy approved in United States?
biological therapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for biological therapy in United States?
NSABP Foundation Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.